The floor is $2.71US+ brokers cut Giving the size of the offering I doubt these brokers manage to sell all of the equities to one stakeholder hopefully I am wrong as many mentioned a single large holder would bring credibility along with analysts working with them.
Apart from some costs involved to close a deal like this these brokers need to sell the equities with a premium which bring me to the fact it is in their interest for the SP in the next few days. Weeks incorporate that premium.
Point is they ultimately want the SP rise from the bought deal price the higher it gets the more profit for the brokers.
After that the trick is the company keep the new investors convinced to hold on to their position as there is no immediate or medium term need for additional funding and they have two potential very lucrative programs which have promising prospects in 2021 and beyond add to that two commercialized drugs with growing sales.